Browse Category

Investment Analysis News 21 December 2025

Amicus Therapeutics Stock (FOLD) News: BioMarin’s $14.50 Cash Buyout, Deal Timeline, and the Latest Forecasts (Dec. 21, 2025)

Amicus Therapeutics Stock (FOLD) News: BioMarin’s $14.50 Cash Buyout, Deal Timeline, and the Latest Forecasts (Dec. 21, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (NASDAQ: FOLD) has effectively shifted from a “biotech story stock” to a deal-driven stock. The reason is simple and decisive: BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to acquire Amicus in an all-cash
Oracle Stock (ORCL) Week Ahead: TikTok Joint Venture Headlines, OpenAI “Stargate” Spending Fears, and Key Levels to Watch (Dec. 22–26, 2025)

Oracle Stock (ORCL) Week Ahead: TikTok Joint Venture Headlines, OpenAI “Stargate” Spending Fears, and Key Levels to Watch (Dec. 22–26, 2025)

Published: December 21, 2025 Oracle Corporation (NYSE: ORCL) heads into a holiday-shortened Christmas trading week with two powerful forces pulling the stock in opposite directions: a fresh catalyst from the newly signed TikTok U.S. joint venture agreement, and ongoing investor
NVIDIA Stock (NVDA) Week Ahead: China H200 Export Review, Intel Investment Clearance, and Blackwell Demand in Focus (Dec. 22–26, 2025)

NVIDIA Stock (NVDA) Week Ahead: China H200 Export Review, Intel Investment Clearance, and Blackwell Demand in Focus (Dec. 22–26, 2025)

NVIDIA Corporation (NASDAQ: NVDA) heads into the Christmas-shortened trading week with a rare mix of policy-driven upside and policy-driven risk. By Sunday, 21.12.2025, the stock’s near-term narrative has become less about “AI demand” in the abstract—and more about who can
Space & Satellite Tech Stocks Week Ahead: Rocket Lab’s $816M Space Force Win, AST SpaceMobile’s BlueBird 6 Launch, and EchoStar’s Spectrum Spotlight

Space & Satellite Tech Stocks Week Ahead: Rocket Lab’s $816M Space Force Win, AST SpaceMobile’s BlueBird 6 Launch, and EchoStar’s Spectrum Spotlight

Holiday-shortened trading weeks can be deceptively eventful for space and satellite tech stocks: lower liquidity tends to amplify moves, while “hard” catalysts like contract awards, launch milestones, and regulatory headlines still land on the tape. Heading into the week of
Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

Military tech stocks are heading into the Christmas-shortened trading week with fresh catalysts from December 19–21 that reinforce a clear narrative: modern defense spending is tilting toward space-based sensing, low-cost drones, and software-heavy systems—while investors debate how much of that
Pfizer Stock (PFE) News Today: 2026 Guidance, Analyst Forecasts, Dividend Outlook, and Pipeline Catalysts (Updated Dec. 21, 2025)

Pfizer Stock (PFE) News Today: 2026 Guidance, Analyst Forecasts, Dividend Outlook, and Pipeline Catalysts (Updated Dec. 21, 2025)

Pfizer Inc. (NYSE: PFE) is heading into 2026 with a familiar mix of strengths and stress fractures: a fortress-scale commercial footprint and one of Big Pharma’s deepest development machines—paired with fading COVID-era revenue, looming loss-of-exclusivity headwinds, and heightened political pressure
Netflix Stock (NFLX) News Today — Dec. 21, 2025: Warner Bros. Deal Battle, Analyst Forecasts, and What Investors Watch Next

Netflix Stock (NFLX) News Today — Dec. 21, 2025: Warner Bros. Deal Battle, Analyst Forecasts, and What Investors Watch Next

Netflix, Inc. (NASDAQ: NFLX) is ending 2025 with a rare mix of big-company stability and big-company drama: strong operating momentum, a fast-growing advertising business, and a headline-grabbing push to acquire major Warner Bros. Discovery assets—while analysts argue over whether the
1 66 67 68 69 70 229
Go toTop